GlassScriptBaylis Medical Technologies INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$201Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
295clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Timothy Clark | Philadelphia, PA | Vascular & Interventional Radiology | $47,025.00 |
| Marcelo Guimaraes | Charleston, SC | Vascular & Interventional Radiology | $30,368.76 |
| Mark Lessne | Charlotte, NC | Diagnostic Radiology | $16,850.00 |
| Joseph Gemmete | Ann Arbor, MI | Vascular & Interventional Radiology | $13,800.00 |
| Henri Justino | San Diego, CA | Pediatric Cardiology | $11,621.59 |
| Khashayar Farsad | Portland, OR | Vascular & Interventional Radiology | $10,112.50 |
| Reza Jahan | Los Angeles, CA | Neuroradiology | $9,937.27 |
| Venu Vadlamudi | South Bend, IN | Diagnostic Radiology | $8,804.00 |
| Martin Radvany | Lakeland, FL | Vascular & Interventional Radiology | $7,301.11 |
| Charles Kim | Durham, NC | Vascular & Interventional Radiology | $6,300.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.